U.S. market Closed. Opens in 1 day 29 minutes

OPRX | OptimizeRx Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue71.52M62.45M61.29M43.31M24.60M21.21M12.13M7.75M7.22M6.50M4.96M2.05M1.11M71.06K26.72K83.69K100.32K
Cost of Revenue28.62M23.48M25.65M19.21M9.16M9.00M6.17M3.41M3.62M3.22M1.77M115.36KN/AN/A2.65MN/AN/A
Gross Profit42.90M38.97M35.64M24.11M15.44M12.21M5.95M4.34M3.60M3.28M3.19M1.93M1.11M71.06K-2.62M83.69K100.32K
Operating Expenses69.30M51.26M35.28M26.24M19.13M12.03M8.08M5.87M4.20M3.91M2.97M2.41M2.57M1.92M2.67M1.59M456.26K
Selling, General & Admin53.72M49.24M33.19M24.16M17.85M11.71M7.76M5.24M3.32M3.45M2.78M2.23M2.57M1.72M2.40MN/AN/A
Research & DevelopmentN/AN/AN/A1.08M2.67M675.66K1.01M398.40K290.37K189.57K130.29K126.92KN/A78.44KN/AN/AN/A
Other Operating ExpensesN/A2.02M2.09M994.75K-1.39M449.00K324.55K235.28K583.95K264.34K193.97K187.10K2.57M119.08K277.86K1.59M456.26K
Operating Income-26.40M-12.29M482.23K-1.89M-3.69M180.13K-2.13M-1.58M-597.41K-1.03M215.60K-364.35K-1.45M-1.85M-2.65M-1.51M-355.94K
Other Expenses / Income1.24M852.30K16.98K-71.81K-346.97K46.21K25.94K42.31K2.27K935.00246.00369.00-666.78K-162.79K738.43K-2.74M-5.53K
Before Tax Income-25.16M-11.44M378.08K-2.21M-4.04M226.34K-2.10M-1.54M-595.14K-1.03M215.85K-363.98K-2.12M-2.01M-4.56M-4.25M-361.47K
Income Tax Expenses-7.60M-852.30K104.15K176.61K-897.96K46.21KN/AN/A2.27KN/A426.00469.00958.64K165.70K1.03K611.00N/A
Net Income-17.57M-10.59M273.93K-2.38M-3.14M226.34K-2.10M-1.54M-595.14K-1.03M215.85K-363.98K-2.12M-2.01M-4.56M-4.25M-361.47K
Interest Expenses1.45M852.30KN/AN/AN/AN/AN/AN/AN/AN/AN/A100.00958.64K106.55K1.03K611.005.53K
Basic Shares Outstanding17.12M17.78M17.23M14.83M13.39M11.32M9.82M9.90M8.19M7.46M4.80M4.74M4.64M4.41M4.19M4.00M690.41K
Diluted Shares Outstanding17.12M17.78M17.69M14.83M13.39M11.86M9.82M9.90M8.19M7.46M7.07M4.74M4.64M4.41M4.19M4.00M690.41K
EBITDA-21.31M-9.42M2.33M-59.43K-2.76M1.24M-1.81M-1.30M-261.19K-761.05K409.82K-267.35K-1.02M-1.78M-4.52M-4.22M-353.12K
EBITDA Margin-29.79%-15.08%3.80%-0.14%-11.21%5.83%-14.89%-16.82%-3.62%-11.70%8.27%-13.05%-91.48%-2,509.52%-16,922.29%-5,037.99%-352.00%
EBIT-23.71M-10.59M378.08K-2.21M-4.04M272.56K-2.10M-1.54M-592.87K-1.03M216.27K-363.41K-203.48K-1.74M-4.55M-4.25M-355.94K
EBIT Margin-33.15%-16.95%0.62%-5.10%-16.43%1.29%-17.35%-19.86%-8.21%-15.77%4.36%-17.74%-18.31%-2,443.92%-17,040.09%-5,075.68%-354.81%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙